|
Ever since its inception, Claris has focused not only in developing its domestic market, but also overseas markets as well. So much so, almost 50% or more of Claris’ revenue is generated from the international markets, through a sales and distribution network spread across many countries.
Critical success factors for manufacturing and marketing pharmaceutical products for international markets are:
1.Regulatory Approvals of the manufacturing unit
2.Registration of Product
3.Established Sales & Distribution network
International Market Coverage:
Our International business division markets products across various therapies worldwide that can be categorized across 3 main businesses for Claris:
1.Critical Care: Therapies include Anesthesia, Clinical Nutrition, Plasma Volume Expanders & Blood Products
2.Renal & Oncology: Peritoneal Dialyses, Transplant Medicine, Chemotherapeutic agents and Oncology & Renal support care products.
3.Hospital Care: This division markets hospital products like Common Infusion solutions, Electrolytes and Anti infectives
Major Markets across the world serviced by Claris team of 115+ Local nationals, 25+ Indian expatriates, 2000+-distributors/ business associates covers are as follows:
1. Emerging Markets:
1.Latin America – Mexico, Brazil
2.Middle East – Gulf Council Countries
3.S.E. Asia – Sri Lanka, Indonesia
4.CIS – Uzbekistan, Kazakhstan, Russia
5.Africa – Sudan, Kenya
2. Developed markets: USA, EU, Nordic, Australasian and Far East markets. Claris’ long term growth and increased profitability in operations will continue with the year on year increasing contribution from these developed or regulated markets.
Claris over the years has been able to setup a huge proprietary sales and distribution network and has set up subsidiaries and offices across major markets. These offices along with the corporate head quarters in India play an important role in managing international operations efficiently.
Claris image and branding have been established through regular and award winning participation in International Pharma Business and Medical Conferences, CMEs, and other CRM activities.
For Claris, International business has always remained an area of successful strategic business growth, and will remain so in the years to come.
|
